Status:

COMPLETED

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

Lead Sponsor:

Bristol-Myers Squibb

Conditions:

Heart Failure

Cardiac Failure

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate the effects of BMS-986231 on systolic and diastolic parameters in patients with heart failure and low ejection fraction.

Eligibility Criteria

Inclusion

  • For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
  • Heart failure with reduced ejection fraction (LVEF on echocardiogram of 40% or less)
  • Stable guideline directed therapy for heart failure including oral diuretics, ACEi, ARBs, ARNi, MRAs, and β blockers as tolerated, with no dose changes of these medications in the past 2 weeks
  • Have screening values of NT pro-BNP ≥ 125 pg/mL (15 pmol/L) or BNP ≥ 35 pg/mL (10 pmol/L)

Exclusion

  • Systolic blood pressure (SBP) \< 110 mm Hg at screening or pre-randomization
  • Heart rate \< 50 beats per minute (bpm) or \> 90 bpm at screening or pre-randomization
  • Permanent Atrial Fibrillation, Atrial Flutter or having Atrial Fibrillation, Atrial Flutter
  • Estimated glomerular filtration rate (eGFR) \< 15 ml/min/1.73 m2
  • Ventricular assist device or prior heart transplant
  • Prior solid organ transplant
  • Body weight \< 45 kg or ≥ 140 kg
  • Low quality echocardiographic visualization windows and image acquisition
  • Permanent paced rhythm (VVI, DDD or BiV pacing)
  • Other protocol defined inclusion/exclusion criteria could apply

Key Trial Info

Start Date :

November 30 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 10 2019

Estimated Enrollment :

49 Patients enrolled

Trial Details

Trial ID

NCT03357731

Start Date

November 30 2017

End Date

May 10 2019

Last Update

July 27 2020

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Orange County Research Center

Tustin, California, United States, 92780

2

Northwestern Medicine

Chicago, Illinois, United States, 60611

3

Indiana University School of Medicine-Indianapolis

Indianapolis, Indiana, United States, 46202-1218

4

Brigham and Womens Hospital

Boston, Massachusetts, United States, 02115